The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration-Reference-Cited by-同舟云学术

The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration

Published:2012-05 Issue:5 Volume:10 Page:556-569
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Qin Jichao,Liu Xin,Laffin Brian,Chen Xin,Choy Grace,Jeter Collene R.,Calhoun-Davis Tammy,Li Hangwen,Palapattu Ganesh S.,Pang Shen,Lin Kevin,Huang Jiaoti,Ivanov Ivan,Li Wei,Suraneni Mahipal V.,Tang Dean G.

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference41 articles.

1. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands;Abrahamsson;Prostate,1988

2. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells;Bhatia;J. Biol. Chem.,2008

3. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study;Chan;Science,1998

4. Prospective identification of tumorigenic prostate cancer stem cells;Collins;Cancer Res.,2005

5. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer;Davis;Cancer Res.,2006

Cited by 269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy;Cancer Letters;2024-10

2. L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells;The Prostate;2024-08-18

3. Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells;Cell Stem Cell;2024-08

4. Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer;2024-07-01

5. Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer;2024-07-01